MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2009-2570

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2010

Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.

Berg Christian, Petersenn Stephan, Lahner Harald, Herrmann Burkhard L, Buchfelder Michael, Droste Michael, Stalla Günter K, Strasburger Christian J, Roggenbuck Ulla, Lehmann Nils, Moebus Susanne, Jöckel Karl-Heinz, Möhlenkamp Stephan, Erbel Raimund, Saller Bernhard, Mann Klaus, Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT: Data on cardiovascular risk in acromegaly are scanty and lack a clear correlation to epidemiological data.

OBJECTIVE

Our aim was an evaluation of cardiovascular risk factors in patients with active acromegaly, a calculation of the Framingham risk score (FRS) compared with age- and gender-matched controls of the general population, and an evaluation of the effect of IGF-I normalization.

DESIGN AND

SETTING

We conducted a retrospective, comparative study at a university referral center.

PATIENTS: A total of 133 patients with acromegaly (65 men, aged 45-74 yr) from the German Pegvisomant Observational Study were matched to 665 controls from the general population.

MAIN OUTCOME MEASURES: Risk factors were measured at baseline and after 12 months of treatment with pegvisomant (n=62).

RESULTS

Patients with acromegaly had increased prevalence of hypertension, mean systolic and diastolic blood pressure (BP), history of diabetes mellitus and glycosylated hemoglobin (all P<0.001) and decreased high-density lipoprotein, low-density lipoprotein, and total cholesterol (all P<0.001). FRS was significantly higher in patients with acromegaly compared with controls (P<0.001). At 12 months, systolic BP (P=0.04) and glycosylated hemoglobin (P=0.02) as well as FRS (P=0.005) decreased significantly. IGF-I was normalized in 62% (41 of 62). In these patients, glucose and systolic and diastolic BP was significantly lower than in partially controlled patients.

SUMMARY: We found an increased prevalence of cardiovascular risk factors in acromegalic patients compared with controls. Control of acromegaly led to a significant decrease of FRS, implying a reduced risk for coronary heart disease. This was most significant in those patients who completely normalized their IGF-I levels.

CONCLUSION

Disease control is important to reduce the likelihood for development of coronary heart disease.

Для цитирования: Berg Christian, Petersenn Stephan, Lahner Harald, Herrmann Burkhard L, Buchfelder Michael, Droste Michael, Stalla Günter K, Strasburger Christian J, Roggenbuck Ulla, Lehmann Nils, Moebus Susanne, Jöckel Karl-Heinz, Möhlenkamp Stephan, Erbel Raimund, Saller Bernhard, Mann Klaus, Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators. Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.. The Journal of clinical endocrinology and metabolism. 2010. DOI: 10.1210/jc.2009-2570.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.